Developing an HIV vaccine

Science. 2017 Mar 17;355(6330):1129-1130. doi: 10.1126/science.aan0662. Epub 2017 Mar 16.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • AIDS Vaccines / immunology*
  • Animals
  • Clinical Trials as Topic
  • HIV Envelope Protein gp120 / genetics
  • HIV Envelope Protein gp120 / immunology
  • HIV Infections / prevention & control*
  • HIV Infections / therapy
  • HIV Protease / genetics
  • HIV Protease / immunology
  • Humans
  • Immunogenicity, Vaccine*
  • Mice
  • Protein Multimerization
  • T-Lymphocytes, Cytotoxic / immunology
  • Vaccines, Synthetic / immunology
  • gag Gene Products, Human Immunodeficiency Virus / genetics
  • gag Gene Products, Human Immunodeficiency Virus / immunology

Substances

  • AIDS Vaccines
  • HIV Envelope Protein gp120
  • Vaccines, Synthetic
  • gag Gene Products, Human Immunodeficiency Virus
  • HIV Protease